Announcing $1.6 million in seed funding led by Pillar VC additional participation from Accanto Partners
We are thrilled to announce that Adaptilens has secured $1.6 million in seed funding, led by Pillar VC with additional support from Accanto Partners. This funding marks an exciting step forward in our mission to revolutionize vision correction with our innovative accommodating intraocular lenses, restoring the eye’s natural ability to focus.
